I
mmune homeostasis is indispensable to tissue development, regeneration, and repair (1) . Trauma initiates a cascade of local and systemic immune events that trigger the mobilization of cells into the damaged site to initiate host defense and tissue repair. The limited success achieved to date in rebuilding human tissues may be due in part to the tendency for therapeutic strategies to target later processes in wound healing and regeneration, such as stem cell differentiation. Conversely, the immune system is a highly flexible network that serves as a guardian of tissue integrity and is adapted to the nature of the local microenvironment (2) . The immune system participates in tissue repair by scavenging debris and dead cells (3) , recruiting and supporting the proliferation of tissue progenitor cells (4) , and inducing vascularization (5) . Previously, immune responses to biomaterials were related to rejection (6) (7) (8) ; however, subsets of innate immune cells have been identified as important mediators of scaffold remodeling (9) (10) (11) and can be targeted for immune-mediated tissue regeneration. We explored the role of adaptive immunity in tissue regeneration, identifying T H 2 responses as critical in driving the repair of traumatic tissue injury.
To model a traumatic wound, we surgically excised a portion of the quadriceps muscle group in C57BL/6 mice, provoking an irreversible volumetric muscle loss (VML) injury (12) . Based on the regenerative potential and clinical use of tissue-derived extracellular matrix (ECM) scaffolds (10, 11), we screened and selected boneand cardiac muscle-derived tissue ECM scaffolds (B-ECM and C-ECM) for their immunomodulatory properties [fig. S1 (13) ]. The presence of scaffolds in damaged muscle significantly increased the number of myeloid cells (F4/80 + macrophages and CD11c + dendritic cells; P < 0.0001) and lymphocytes (CD3 + T cells and CD19 + B cells; P < 0.05) present at the injury site as compared to a salinetreated control after 1 and 3 weeks (Fig. 1A and  fig. S2 ). At 1 week, collagen-treated wounds recruited the highest number of immune cells into the defect region (36.0% of total live cells, 13.6 million cells) followed by B-ECM-and C-ECMtreated wounds (39.3%, 5.32 million; and 45.4%, 5.44 million cells), with saline-treated wounds containing significantly fewer cells (36.4%, 0.97 million). The proportion of myeloid cells in the damaged muscle peaked at 1 week after injury, and the T cell fraction, consisting of both CD4 + and CD8 + cells, peaked in all treatment groups at 3 weeks after injury. In the muscle wound, biomaterial scaffolds skewed the ratio of CD4:CD8 T cells toward a higher fraction of CD4 + helper T cells (~70% in scaffold-treated, versus~50% in saline-treated wounds) at 1 week after injury (Fig.  1B) . CD4 +
FoxP3
+ regulatory T cells were also present at low levels and increased over time ( fig. S3 ).
The expression of interleukin 4 (Il4), a gene encoding a canonical type 2 helper T cell (T H 2) cytokine that is also important in muscle healing (14) (15) (16) (17) , increased in the presence of the scaffold (Fig. 1C) . Therefore, we sought to understand the role of cells of the adaptive immune system on the formation of the regenerative immune microenvironment. Scaffolds were implanted into B6.129S7-Rag1 tm1Mom /J (Rag1 −/− ) mice, which lack mature T and B cells. In Rag1 −/− mice, scaffoldmediated Il4 up-regulation was lost, suggesting a T H 2-driven scaffold immune microenvironment. CD3 + cells were sorted out of muscle injuries at 1 week after injury for detailed gene expression analysis (Fig. 1D, fig. S4 , and table S1). Scaffolds induced a T H 2-type gene expression profile as characterized by increased Il4 expression and decreased expression of Ifng and Tbx21 (T H 1 canonical genes). In addition, Jag2, which encodes the Notch ligand Jagged 2, was elevated. Jagged2 helps direct T H differentiation away from T H 1 and toward T H 2 (18) . Il10, which encodes a general anti-inflammatory cytokine that is not T Hspecific, was also up-regulated. Other genes that are more selectively expressed by T H 1 cells, such as Fasl and Cd28 (the costimulatory receptor for CD86), were likewise down-regulated.
The regenerative outcome of tissue-derived ECM scaffolds in animals and humans is correlated with an immunoregulatory M2 macrophage phenotype during remodeling (9) (10) (11) . Biomaterials increased the expression of genes associated with a pro-regenerative type 2 immune response, including hallmark genes of M2 myeloid cells, more specifically macrophages that are stimulated by IL-4, known as M(IL-4) macrophages (fig. S5) (19) . As with Il4 expression, induction of these M(IL-4) markers was almost completely lost in Rag1 −/− mice ( fig. S5 ). In the presence of adaptive immune cells, biomaterial scaffolds inhibited macrophage CD86 up-regulation (a costimulatory molecule expressed at high levels by classical M1 macrophages) at 3 weeks after surgery ( Fig.  2A and fig. S6H ). In Rag1 −/− mice, however, downregulation of CD86 expression was mitigated, and ECM scaffold-treated wounds returned to a macrophage polarization profile resembling that of saline-treated control animals ( Fig. 2A ). On the other hand, CD206 expression (a mannose receptor and classical M2 marker) was similar between ECM scaffold-treated and saline-treated mice at 1 week after implantation, with increased expression at 3 weeks (Fig. 2B ). However, this increase in CD206 was ablated in Rag1 −/− mice in both scaffold-and saline-treated wounds, suggesting that the adaptive immune system also has a scaffold-independent role in shaping the wound healing response. Moreover, this CD206 upregulation was also impaired in B6.129S2-Cd4 Fig. 2, C and D) . Compared to WT controls, myeloid cells in Il4ra −/− wounds expressed far lower levels of CD206, suggesting that the macrophage activation was controlled by IL-4, and verifying that the pro-regenerative profile is associated with M(IL-4) cells.
The pleiotropic nature of immune responses typically results in complex expression profiles beyond stereotypical M1 versus M2 "poles" (19) . The expression of CD86 and the expression of CD206 on macrophages (classically M1 versus M2) were not mutually exclusive; however, these scaffold-associated macrophages also up-regulated the expression of genes encoding Arg1 and Retnla (encoding Fizz1), similar to the results from quantitative reverse transcription polymerase chain reaction (qRT-PCR) analyses of the whole wound (Fig. 2E and fig. S5 ). Additionally, Cebpb, and Timp1 were up-regulated, whereas Mmp16 and Mmp9 were down-regulated, further suggesting a pro-regenerative function of the scaffoldassociated macrophages (21) (22) (23) . In Rag1 −/− mice, which cannot mount a T H 2 immune response, scaffold-associated macrophages lost their proregenerative transcriptome (Fig. 2F, fig. S8 , and response in the bloodstream, but the connection to wound healing and regeneration is unknown (28, 29) (Fig. 3 and fig. S10 ). Scaffold treatment induced hypertrophy of local draining lymph nodes (Fig. 3A) , which accompanied a robust increase in Il4 expression (Fig. 3B and fig. S10 ).
This Il4 induction was absent at 1 week after injury in Rag1 −/− mice but present after 3 weeks, suggesting an early adaptive immune-dependent Il4 up-regulation followed by an innate immunedriven Il4 up-regulation later in the wound healing and regeneration processes. Additionally, Cd4 −/− mice displayed a significant decrease in scaffold-mediated Il4 up-regulation in inguinal lymph nodes at 3 weeks after injury in C-ECMtreated animals (Fig. 3B) scaffold-induced systemic type 2 immunity, but with potential further contributions by B cells or CD8 + T cells.
Functionally, WT animals recovered to be able to run distances similar to those of healthy uninjured counterparts after 6 weeks (Fig. 4A) .
However, this restoration of running capacity was ablated in the absence of T and B cells (Rag1 . Data are means ± SEM, n = 4 mice (representative of at least two independent experiments), ANOVA: ****P < 0.0001, **P < 0.01, *P < 0.05. Muscle structure correlated with the differences in functional capacity. Histologically, at 6 weeks after injury, the quadriceps muscle treated with the C-ECM scaffold appeared similar to that of healthy controls, with minimal scaffold visible and repair tissue fully integrated within the surrounding musculature. A large region of fibrous tissue with active inflammation was present in muscles treated with the collagen scaffold (Fig.  4C and fig. S11 ). Rag1 −/− mice displayed increased adipose deposition, fibrosis, scaffold persistence, and smaller-diameter muscle fibers than their WT counterparts. At 3 weeks after injury, centrally nucleated muscle fibers, which are indicative of active regeneration or recovery from injury, were present within the biomaterial scaffold and around the defect site ( Fig. 4D and fig. S12 ). WT mice produced muscle with larger, more rounded fibers, whereas Rag1 −/− mice muscles contained smaller, irregularly shaped fibers, indicating a defect in muscle regeneration. In addition, the pathologic Rag1 −/− histomorphology was recapitulated in Cd4 −/− mice, confirming the role of CD4 + T cells in fibro-adipogenic lineage commitment (Fig. 4D) . Increased gene expression of Adipoq (adiponectin) confirmed ectopic adipogenesis in Rag1 −/− whole muscle. Similarly, the expression of Col1a1 (type I collagen) increased in Rag1 −/− mice muscles, highlighting increased fibrosis ( Fig.  4E and fig. S13 ). Although scaffold treatment reduced fibro-and adipogenesis markers in WT animals, this benefit was lost in Rag1 −/− mice.
We have demonstrated that tissue-derived biomaterial scaffolds enhance the development of a pro-regenerative immune environment and have implicated adaptive immune cells, specifically mTORC2-dependent CD4 + T H 2 T cells, in the process of functional tissue restoration ( fig. S14 ). Just as cancer research has made great strides in T cell therapies, these concepts can be translated to biomaterials design to improve tissue repair and regeneration (30) (31) (32) (33) .
